More CEO watchers put Gilead's Martin on their 'best of 2014' lists

End-of-year bouquets are piling up for Gilead Sciences ($GILD) CEO John Martin. After winning top reviews from the Harvard Business Review for his 2014 performance, Martin has picked up a "best CEO" nod from a prof at Dartmouth's Tuck School of Business. And the investing site Motley Fool puts him among the year's three "most exceptional" corporate chiefs. Report

Suggested Articles

Novartis is taking its MBC campaign to Instagram with a newly launched video series as part of the five-year “Make Your Dialogue Count” effort.

FDA researchers uncover more concerns and fears among front-line workers and minority groups about a COVID-19 vaccine.

Provention Bio wants to connect the familial threads around Type 1 diabetes with two new campaigns—one targeted at doctors and the other at consumers.